Ideal regimen for induction chemotherapy in nasopharyngeal cancer: Still a hot issue?

Affiliations

¹ Radiation Oncology, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Viale Regina Elena 326, 00161 Rome, Italy. Electronic address: fradefelice@hotmail.it.
² Medical Oncology Unit B, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Viale Regina Elena 326, 00161 Rome, Italy.

Editorial

Francesca De Felice et al. Radiother Oncol. 2022 Dec.

. 2022 Dec:177:111-112.

doi: 10.1016/j.radonc.2022.10.033. Epub 2022 Nov 3.

¹ Radiation Oncology, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Viale Regina Elena 326, 00161 Rome, Italy. Electronic address: fradefelice@hotmail.it.
² Medical Oncology Unit B, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Viale Regina Elena 326, 00161 Rome, Italy.

No abstract available

Keywords: Cisplatin; Gemcitabine; Induction chemotherapy; Nasopharynx; Radiotherapy; Taxane.

Publication types